Internal Medicine, Transplant Hepatology · New York, NY
NPI
1932131075
Since 2006
Specialty
Internal Medicine, Transplant Hepatology
Code 207RT0003X
Group practices
5
Medicare group memberships
Hospitals
4
Hospital affiliations
317 E 34th St Fl 8
New York, NY, 10016
Phone (212) 263-8133
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
158 services
Medicare patients, 2024
76
Average age 69
Drug cost, 2024
$594K
1,031 prescriptions
Company payments, 2025
$126K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nikolaos T Pyrsopoulos was code 99232 (hospital e&m - subsequent), 51 times for 12 patients. In total Nikolaos T Pyrsopoulos billed 158 services in 14 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 51 | 12 | $67.22 | $3,428 |
| 99214 Office E&M - Established | Facility | 40 | 30 | $70.34 | $2,814 |
| 99214 Office E&M - Established | Office | 19 | 16 | $109.67 | $2,084 |
By year: 2022 $13K for 163 services; 2023 $22K for 278 services; 2024 $13K for 158 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nikolaos T Pyrsopoulos prescribed most often to Medicare patients was Tacrolimus, with 204 prescriptions and refills. In total Nikolaos T Pyrsopoulos wrote 1,031 Medicare prescriptions that cost $594K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tacrolimus Generic | 204 | 332 | 53 | $19K |
| Mycophenolate Mofetil Generic | 87 | 137 | 24 | $8,511 |
| Xifaxan Rifaximin | 73 | 73 | 15 | $236K |
| Mycophenolic Acid Mycophenolate Sodium | 67 | 108 | 21 | $26K |
| Furosemide Generic | 57 | 70 | 18 | $132 |
| Carvedilol Generic | 48 | 52 | 12 | $280 |
| Pantoprazole Sodium Generic | 41 | 51 | 13 | $174 |
| Ursodiol Generic | 39 | 74 | 13 | $7,225 |
| Everolimus Generic | 36 | 38 | Under 11 | $53K |
| Entecavir Generic | 31 | 51 | Under 11 | $15K |
| Vemlidy Tenofovir Alafenamide | 29 | 43 | Under 11 | $59K |
| Hydroxyzine Hcl Generic | 28 | 28 | Under 11 | $527 |
| Fludrocortisone Acetate Generic | 26 | 28 | Under 11 | $182 |
| Spironolactone Generic | 25 | 36 | Under 11 | $224 |
| Amlodipine Besylate Generic | 25 | 35 | Under 11 | $82.33 |
Brand drugs: - claims; generic drugs: 867 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nikolaos T Pyrsopoulos $126K ($126K in general payments such as food, travel and fees) from 14 companies. The largest payer was Novo Nordisk Inc with $44K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 19 | $44K |
| Madrigal Pharmaceuticals MDGL | 32 | $41K |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 13 | $30K |
| Bausch Health US, LLC BHC | 3 | $6,525 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $2,599 |
| Gilead Sciences, Inc. GILD | 11 | $2,504 |
| Abbvie Inc. ABBV | 3 | $56.99 |
| Intercept Pharmaceuticals, Inc. | 2 | $38.83 |
| Eisai Inc. 4523.T | 2 | $35.35 |
| Exact Sciences Corporation EXAS | 1 | $31.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.